newsfilter
← Latest News
GlobeNewswire·

Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference

  • Eton Pharmaceuticals will host 1x1 meetings on September 9, 2026, at the Wells Fargo Healthcare Conference in Boston, MA.
  • The 2026 Wells Fargo Healthcare Conference is scheduled to take place from September 8-10, 2026.
  • The company currently markets eleven commercial rare disease products, including KHINDIVI, INCRELEX, ALKINDI SPRINKLE, DESMODA, GALZIN, HEMANGEOL, PKU GOLIKE, IMPAVIDO (launching September 2026), Carglumic Acid, Betaine Anhydrous, & Nitisinone.
  • Eton has five product candidates in late-stage development: ASN-001, AMGLIDIA, ET-700, ET-800, & ZENEO hydrocortisone autoinjector.
  • Interested parties must contact their Wells Fargo institutional sales representative to schedule a meeting with the executive leadership team.
  • Investor relations inquiries can be directed to Lisa M. Wilson at In-Site Communications, Inc.